Who Won It

Contract award · 5 Nov 2025

Leuprorelin (Prostap®)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Leuprorelin (Prostap®)” to Takeda UK Ltd for £2.63m.

No competitionMedical equipment & pharmaceuticalsScotland

BuyerThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value £2.63m
WinnerTakeda UK Ltd

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
Supplier
Takeda UK Ltd
Value
£2,625,907
Procedure
Negotiated without publication of a contract notice
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Official notice
071242-2025 on Find a Tender
Timeline
  1. Contract date5 Nov 2025
  2. Published5 Nov 2025Published the same day

Description

Supply of Leuprorelin (Prostap®) to NHS Scotland. The Authority has awarded this framework as a single supplier framework per line to one (1) Framework Participant. II.2.11) Information about option.

About the supplier

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
5 Nov 2025
Takeda UK Ltd £2.63m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Takeda UK Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview